Skip to main content
. 2019 Dec 26;10(2):645–664. doi: 10.1534/g3.119.400910

Table 6. Statistically Significant BMI PheWAS SNPs including DM2 as a comorbidity.

Phenotype Description SNP Gene β (SE) Odds Ratio PheWAS p-value N Cases Controls
250.2 Type 2 Diabetes rs2246606 TDH -0.331 0.073 0.718 6.32x10-6 5566 459 5107
796 Elevated prostate specific antigen [PSA] rs9937053 FTO 0.882 0.197 2.416 7.76x10-6 6293 71 6222
796 Elevated prostate specific antigen [PSA] rs9930333 FTO 0.881 0.197 2.413 7.88x10-6 6297 71 6226
796 Elevated prostate specific antigen [PSA] rs9940128 FTO 0.875 0.197 2.398 8.66x10-6 6297 71 6226
796 Elevated prostate specific antigen [PSA] rs1121980 FTO 0.872 0.197 2.391 9.60x10-6 6298 71 6227
250 Diabetes Mellitus rs2246606 TDH -0.318 0.072 0.728 1.14x10-5 5577 470 5107
796 Elevated prostate specific antigen [PSA] rs1421085 FTO 0.855 0.197 2.351 1.41x10-5 6298 71 6227
796 Elevated prostate specific antigen [PSA] rs1558902 FTO 0.854 0.197 2.350 1.43x10-5 6298 71 6227
278.1 Obesity rs2948300 N/A 0.199 0.047 1.221 1.90x10-5 5805 1172 4633
796 Elevated prostate specific antigen [PSA] rs17817449 FTO 0.823 0.196 2.277 2.75x10-5 6298 71 6227
796 Elevated prostate specific antigen [PSA] rs8043757 FTO 0.822 0.196 2.275 2.82x10-5 6298 71 6227
250.2 Type 2 Diabetes rs2572386 FAM167A -0.303 0.073 0.739 3.57x10-5 5564 459 5105
278 Obesity, Overweight rs2948300 N/A 0.182 0.044 1.200 3.71x10-5 5980 1347 4633
796 Elevated prostate specific antigen [PSA] rs8050136 FTO 0.788 0.195 2.198 5.55x10-5 6298 71 6227
796 Elevated prostate specific antigen [PSA] rs9939609 FTO 0.787 0.196 2.197 5.71x10-5 6298 71 6227
250.2 Type 2 Diabetes rs1435277 N/A -0.292 0.073 0.747 5.94x10-5 5554 458 5096
401 Hypertension rs12412241 N/A -0.221 0.055 0.802 6.49x10-5 6057 1385 4672
796 Elevated prostate specific antigen [PSA] rs3751812 FTO 0.772 0.195 2.163 7.87x10-5 6297 71 6226
250 Diabetes Mellitus rs2572386 FAM167 -0.284 0.072 0.753 8.44x10-5 5575 470 5105
401.1 Essential Hypertension rs12412241 N/A -0.216 0.056 0.806 1.02x10-4 6037 1365 4672
HHS Vulnerability Disclosure